Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
Viz.ai announced that two research abstracts on its AI-ECG technology within the Viz Cardio Suite were accepted for presentation at the Hypertrophic Cardiomyopathy Medical Society meeting. The meeting is held alongside the American Heart Association's Scientific Sessions 2026 in Chicago. Both studies focus on Viz HCM, the suite's AI-ECG algorithm.
Read the original →A systematic review and meta-analysis found AI models showed 92.0% sensitivity and 87.9% specificity for detecting pediatric appendicular fractures. The description notes that the studies included varied substantially.
Read the original →AI plaque analysis of CCTA scans showed that 27 percent of former NFL players had severe or extensive total plaque volume. The study is to be presented at the American Heart Association Scientific Sessions 2026 this week.
Read the original →Seattle's 911 dispatchers receive live AI prompts to route calls to a nurse line instead of an ambulance. A former city privacy officer says her warnings were ignored.
Read the original →A field study of fourteen cardiothoracic ICU clinicians found that predictive AI tools must demonstrate added clinical value. They must also earn trust through transparency and accuracy.
Read the original →MediQuaid's Jason Tennison told the Scopewell podcast that EHR migrations and legacy archives are the groundwork AI needs. The description says outside data shows the scale.
Read the original →A new review maps the opportunities and obstacles facing digital pathology and AI adoption in Saudi Arabia under Vision 2030.
Read the original →An AI assistant that conducts telephone consultations with patients is being trialled in the NHS. It is intended to help clinicians monitor people with long-term illness.
Read the original →Anthropic is betting that AI can speed up biotech. Scientists warn that claims of curing cancer need clinical proof.
Read the original →The U.S. Department of the Treasury issued a Notice of Proposed Rulemaking on October 22, 2026. It would implement the Comprehensive Outbound Investment National Security (COINS) Act and expand current Outbound Investment Security Program restrictions.
Read the original →Inductive, which describes itself as the chemical intelligence organization for drug discovery, placed first in the OpenADMET CYP Direct Inhibition Blind Challenge.
Read the original →A narrative review traces how deep-learning architectures for surgical video evolved from recurrent networks to transformers. It covers the latency, fusion and edge-deployment constraints these models face.
Read the original →A weekly roundup of policy news in the chemical arena and beyond.
Read the original →Cal State LA hosted the Sikand Symposium on AI and sustainable healthcare on Oct. 29, 2026. The event was held with UCLA, Cedars-Sinai and LA BioStart.
Read the original →An AI system will now be able to prescribe acne medication independently to eligible adults in Utah without doctors' oversight.
Read the original →A JAMA study analyzed 271 million AI questions from 952,008 US clinicians, including 556,200 physicians. The description says it covers what they ask and what the data cannot show.
Read the original →GENSHI AI, based in Chiyoda, Tokyo, will handle operation of the certification exam hosted by the Medical Generative AI Promotion Association and production of its official textbook. Pre-orders for the textbook have opened. Sales are planned to begin in stages from December 2026.
Read the original →Deputy government spokesperson Padarat said on November 6 that the Ministry of Higher Education, Science, Research and Innovation is promoting a health economy strategy using science, technology and advanced innovation. The plan is to advance nationwide practical use of medical AI and precision medicine and develop Thailand into a health and longevity hub for Asia.
Read the original →